Page last updated: 2024-08-26

bosentan anhydrous and Dermatitis

bosentan anhydrous has been researched along with Dermatitis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Enk, A; Hartmann, M; Hartschuh, W; Haust, M; Klein, S; Krammer, PH; Kretz, CC; Kuhn, A; Oberle, N; Ruland, V; Stumpf, C; Suri-Payer, E	1

Other Studies

1 other study(ies) available for bosentan anhydrous and Dermatitis

Article	Year
Reduction of regulatory T cells in skin lesions but not in peripheral blood of patients with systemic scleroderma. Annals of the rheumatic diseases, 2011, Volume: 70, Issue:8 Topics: Adult; Aged; Biopsy; Bosentan; Case-Control Studies; CD4-Positive T-Lymphocytes; Dermatitis; Dermatologic Agents; Endothelin A Receptor Antagonists; Female; Forkhead Transcription Factors; Humans; Immune Tolerance; Male; Middle Aged; Scleroderma, Localized; Scleroderma, Systemic; Skin; Sulfonamides; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory	2011

Article

Year

Reduction of regulatory T cells in skin lesions but not in peripheral blood of patients with systemic scleroderma.

Annals of the rheumatic diseases, 2011, Volume: 70, Issue:8

Topics: Adult; Aged; Biopsy; Bosentan; Case-Control Studies; CD4-Positive T-Lymphocytes; Dermatitis; Dermatologic Agents; Endothelin A Receptor Antagonists; Female; Forkhead Transcription Factors; Humans; Immune Tolerance; Male; Middle Aged; Scleroderma, Localized; Scleroderma, Systemic; Skin; Sulfonamides; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory

2011